TDR Trade to Black with Cody Shandraw, the President of the Healing Realty Trust, discusses the next wave of the psychedelic renaissance. Cody has invested in over 50 psychedelic companies, including clinics, drug development, and emerging technologies.
Cody has been looking very closely at the industry and makes his thesis known in this episode about why this might be the time for the next leg up in psychedelic stocks. Cody will also share his thoughts on the upcoming scheduled FDA review for Lykos Therapeutic in August and what may happen to psychedelic stock if approved.
In addition, he looks at catalysts from the large pharmaceutical companies and why these companies are watching the psychedelic space so closely.
The mental health therapies for those suffering from PTSD in the US are so limited, and the demand of those seeking a solution is tremendous. Join us in this episode to look at the potential renaissance for psychedelic stocks and mental health.
#psychedelicstocks #smallcapstocks #ptsd #mentalhealth
Want to see more about psychedelic stocks? Check out these links below.
Numinus:
• Numinus US Strategic Expansion Plan U...
Cybin:
• Cybin Receives Expedited Review FDA B...
Want to be updated on all things Psychedelic, Cannabis, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com...
Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook: / thedalesreport
Twitter: / thedalesreport
Instagram: / dalesreport
Website: https://thedalesreport.com/
For copyright matters please get in touch with us at:
sdales@thedalesreport.com
